1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of concomitant bone-targeted therapies (BTT) on outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) without prior chemotherapy (ctx) treated with abiraterone acetate (AA) or prednisone (P)
    Meeting Abstract

    Saad, F.; Fizazi, K.; Smith, M. R.; Griffin, T. W.; Londhe, A.; Rathkopf, D. E.; Molina, A.; Ryan, C. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Biomarker prediction of chemotherapy-related amenorrhea
    Meeting Abstract

    Ruddy, K. J.; O'Neill, A. M.; Miller, K.; Schneider, B. P.; Baker, E.; Sparano, J. A.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Lymph node metastases in endocervical adenocarcinoma: Correlation with Silva pattern of invasion
    Meeting Abstract

    Rutgers, J. K. L.; Zaino, R. J.; Young, R. H.; Ronnett, B. M.; Longacre, T. A.; Alvarado-Cabrero, I.; Park, K. J.; Roma, A.; Osann, K.; Silva, E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma
    Meeting Abstract

    Ribas, A.; Robert, C.; Daud, A.; Hodi, F. S.; Wolchok, J. D.; Kefford, R.; Patnaik, A.; Hwu, W. J.; Weber, J. S.; Joshua, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II clinical and translational study of MK-2206 in patients with metastatic neuroendocrine tumors (NETs)
    Meeting Abstract

    Reidy, D. L.; Pietanza, M. C.; Segal, M.; Capanu, M.; Saltz, L.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Accent-based nomograms (NGs) to predict time to recurrence (TTR) and overall survival (OS) in stage III colon cancer (CC)
    Meeting Abstract

    Renfro, L. A.; Grothey, A.; Saltz, L.; AndreĢ, T.; Labianca, R.; Alberts, S. R.; Loprinzi, C. L.; Yothers, G.; Sargent, D. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of lirilumab (BMS-986015), an anti-KIR monoclonal antibody, administered in combination with ipilimumab, an anti-CTLA4 monoclonal antibody, in patients (Pts) with select advanced solid tumors
    Meeting Abstract

    Rizvi, N. A.; Infante, J. R.; Gibney, G. T.; Bertino, E. M.; Cooley, S. A.; Lekatis, K.; Wigginton, J. M.; Gutierrez, A. A.; Gupta, A. K.; Kim, S. Y.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) plus platinum-based doublet chemotherapy (PT-doublet) in chemotherapy-naive non-small cell lung cancer (NSCLC) patients (pts)
    Meeting Abstract

    Rizvi, N. A.; Antonia, S. J.; Man Chow, L. Q.; Brahmer, J. R.; Juergens, R. A.; Borghaei, H.; Shepherd, F. A.; Laurie, S. A.; Gerber, D. E.; Wade Goldman, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations
    Meeting Abstract

    Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Clinical impact of an online tool to guide choice of therapy (Tx) for patients (Pts) with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Quill, T. A.; Rini, B. I.; Jonasch, E.; Bowser, A.; Mortimer, J. A.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save